News
-
2024 Annual Report
A Year to Remember!
-Read more-
-
VPHi leads Communication and Dissemination for the dealii-X project - the Exascale Framework for Digital Twins of the Human Body
We are happy to announce VPHi's key role in dealii-X. With its objectives to revolutionise personalised medicine through exascale computing, this initiative promises to break new ground in the field of digital twin and high-performance computing (HPC).
-Read more-
-
In the literature: January 2025 highlights
Click here to read some interesting recently published papers from our community. If you have published an article in the field of in silico medicine, send it to us: we will include it in this section of the newsletter!
-Read more-
-
TEHDAS2 opens public consultation on European Health Data Space implementation guidelines
TEHDAS2, a European Joint Action, is developing guidelines and technical specifications to enable seamless use of health data across Europe under the upcoming European Health Data Space (EHDS). Have your say until the 28th of February!
-Read more-
-
The European Data Protection Board (EDPB) adopts pseudonymisation guidelines
On 16 Jan 2025 the European Data Protection Board published its Guidelines 01/2025 on pseudonymisation, marking the first comprehensive guidance on this data protection measure since the implementation of GDPR.
-Read more-
-
FDA Draft Guidance on Use of AI to Support Regulatory Decision-Making for Drug and Biological Products
On 6 Jan 2024, the FDA released a new draft guidance. Comments on the draft are due by 7 April 2025. This draft takes into consideration the more than 800 comments that FDA received in response to their two discussion papers that were published in 2023.
-Read more-